Abstract:Tetrahydroprotoberberines (THPBs), a class of naturally occurring isoquinoline alkaloids, contain substituent methoxyl or hydroxyl groups which play a significant role in the pharmacological properties of these molecules. In this study, we report a biocatalytic strategy for selective O-demethylation of THPBs. CYP105D1, a cytochrome P450 from Streptomyces griseus ATCC 13273, exhibited markedly regioselective demethylation of nonhydroxyl-THPBs and monohydroxyl-THPBs on the D-ring. A possible binding mode of THPBs with CYP105D1 was investigated by docking analysis, and the results revealed that the D-rings of THPBs were with the minimum distance to the heme iron. Tetrahydropalmatine was used as a model substrate and enantioselective demethylation was demonstrated. (S)-Tetrahydropalmatine was only demethylated at C-10, while (R)-tetrahydropalmatine was first demethylated at C-10 and then subsequently demethylated at C-9. The kcat/Km value for demethylation of (R)-tetrahydropalmatine by CYP105D1 was 3.7 times greater than that for demethylation of (S)-tetrahydropalmatine. Furthermore, selective demethylation of (S)-tetrahydropalmatine by the CYP105D1-based whole-cell system was demonstrated for the highly efficient production of (S)-corydalmine which has distinct pharmacological applications, such as providing relief from bone cancer pain and reducing morphine tolerance. Moreover, a homologous redox partner was identified to enhance the catalytic efficiency of the CYP105D1-based whole-cell system. This is the first enzymatic characterization of a cytochrome P450 that has regio- and enantioselective demethylation activity of THPBs for application purpose. The cytochrome P450 system could be a promising strategy for selective demethylation in the pharmaceutical industry.

Regio- and Enantioselective O-demethylation of Tetrahydroprotoberberines by Cytochrome P450 Enzyme System from Streptomyces Griseus ATCC 13273

An Enzymatic Strategy for the Selective Methylation of High-Value-Added Tetrahydroprotoberberine Alkaloids

Enzyme-catalyzed Regio-Selective Demethylation of Papaverine by CYP105D1

Stereoselective Interaction Between Tetrahydropalmatine Enantiomers and CYP Enzymes in Human Liver Microsomes

Stereoselective Metabolism of Tetrahydropalmatine Enantiomers in Rat Liver Microsomes

Regio- and enantio-selective glycosylation of tetrahydroprotoberberines by Gliocladium deliquescens NRRL1086 resulting in unique alkaloidal glycosides

Diversity Synthesis of Tetrahydroprotoberberines Glycosides by Combined Chemical and Microbial Catalysis.

Concise syntheses of 13-methylprotoberberine and 13-methyltetrahydroprotoberberine alkaloids

An Efficient and Eco‐Friendly Synthesis of Protoberberine and 13‐Me Protoberberine Alkaloids via Electrochemical Acceptorless Dehydrogenation

Design, Synthesis, and Pharmacological Evaluation of Novel Tetrahydroprotoberberine Derivatives: Selective Inhibitors of Dopamine D1 Receptor

Chemical and Microbial Semi-Synthesis of Tetrahydroprotoberberines As Inhibitors on Tissue Factor Procoagulant Activity

Site-selective C-H hydroxylation of pentacyclic triterpenoids directed by transient chiral pyridine-imino groups

Controlling Chemo- and Regioselectivity of a Plant P450 in Yeast Cell Toward Rare Licorice Triterpenoid Biosynthesis

Regio- and stereoselectivity in the CYP450<sub>BM3</sub>-catalyzed hydroxylation of complex terpenoids: a QM/MM study

Regio- and stereoselectivity in the CYP450 BM3 -catalyzed hydroxylation of complex terpenoids: a QM/MM study.

Selective Dehydrogenation on the C Rings of L-Tetrahydropalmatine and Tetrahydroberberine by Verticillium Sp.

Identification of a Novel Cytochrome P450 Enzyme That Catalyzes the C-2α Hydroxylation of Pentacyclic Triterpenoids and Its Application in Yeast Cell Factories

A Biosynthetic Network for Protoberberine Production in Coptis Chinensis

The two enantiomers of tetrahydropalmatine are inhibitors of P-gp, but not inhibitors of MRP1 or BCRP

Production of Heterodimeric Diketopiperazines Employing a Mycobacterium-Based Whole-Cell Biocatalysis System.

Selective P450<sub>BM3</sub> Hydroxylation of Cyclobutylamine and Bicyclo[1.1.1]pentylamine Derivatives: Underpinning Synthetic Chemistry for Drug Discovery